Doxorubicin Completed Phase 3 Trials for Psychosocial Effects of Cancer and Its Treatment / Endometrial Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00002493Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
NCT01767155Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
NCT00003691Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
NCT00005583Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer